Dihexa: Dosage & Administration
Part of the Dihexa Complete Guide
Research Peptides
We may earn a commission if you purchase through this link, at no extra cost to you.
Dihexa Dosage Protocols
Dihexa dosing in research requires extreme caution due to its extraordinary potency — it has been reported to be up to 10 million times more potent than BDNF at promoting synaptogenesis in vitro. This does not translate to 10 million times the cognitive effect, but it does mean that dihexa operates at remarkably low doses compared to other nootropic peptides like semax or selank.
| Protocol | Route | Dose | Frequency | Duration | Notes |
|---|---|---|---|---|---|
| Conservative start | Oral | 5 mg | Once daily | 2 weeks | Assess tolerance before increasing |
| Standard oral | Oral | 10–20 mg | Once daily | 2–4 weeks | Most commonly referenced range |
| Low-dose SC | Subcutaneous | 1–3 mg | Once daily | 2–4 weeks | Higher bioavailability than oral |
| Standard SC | Subcutaneous | 3–5 mg | Once daily | 2–4 weeks | Upper range for experienced users |
| Sublingual (experimental) | Sublingual | 5–10 mg | Once daily | 2 weeks | Limited data, bypasses first-pass |
Dihexa is structurally derived from angiotensin IV and acts by stabilizing hepatocyte growth factor (HGF) against enzymatic degradation. This amplifies HGF/c-Met signaling — the primary pathway driving new synapse formation. The low absolute doses reflect this potent mechanism of action rather than poor absorption.
Important: Research on dihexa is preliminary and dosing guidelines are based on limited animal studies and anecdotal reports. No formal human dose-finding trials have been conducted. Start with the lowest effective dose and titrate conservatively.
Use the dosage calculator to verify volumes for injectable preparations.
Oral vs Injectable: Choosing a Route
Dihexa is unique among research peptides in having meaningful oral bioavailability. Most peptides are destroyed by digestive enzymes, but dihexa's modified hexapeptide structure allows gastrointestinal absorption. This is a key differentiator from compounds like BPC-157 (which also has oral bioavailability) and standard injectable peptides.
| Factor | Oral (Capsule) | Subcutaneous (SC) |
|---|---|---|
| Bioavailability | Moderate (~30–50% estimated) | High (~90%+) |
| Onset | 45–90 minutes | 15–30 minutes |
| Convenience | High — no preparation needed | Requires reconstitution, sterile technique |
| Dose precision | Fixed capsule doses | Adjustable with insulin syringe |
| Typical dose range | 5–20 mg/day | 1–5 mg/day |
| Cost efficiency | Lower (higher doses needed) | Higher (lower doses, less compound used) |
Oral route is preferred by most users for convenience and the elimination of injection requirements. Subcutaneous injection offers higher bioavailability and more precise dose control, which is particularly relevant given dihexa's extreme potency. For details on injection technique, see the injection guide.
Reconstitution & Preparation
Dihexa is available in both capsule (oral) and lyophilized powder (injectable) forms:
Oral Capsules
Pre-dosed capsules require no preparation. Simply take with water. No fasting requirement, though some users prefer dosing on an empty stomach for faster absorption.
Injectable (Lyophilized Powder)
Due to very low dose requirements, concentration calculation is critical to avoid dosing errors:
| Vial Size | BAC Water Added | Concentration | Volume for 2 mg | Volume for 5 mg |
|---|---|---|---|---|
| 10 mg | 1 mL | 10 mg/mL | 0.20 mL (20 units) | 0.50 mL (50 units) |
| 10 mg | 2 mL | 5 mg/mL | 0.40 mL (40 units) | 1.00 mL (100 units) |
| 25 mg | 2.5 mL | 10 mg/mL | 0.20 mL (20 units) | 0.50 mL (50 units) |
Steps:
- Wipe vial top and BAC water vial with alcohol swab
- Draw the desired volume of bacteriostatic water (never saline or sterile water for multi-use)
- Inject slowly down the side of the vial — do not stream directly onto the lyophilized cake
- Gently swirl until dissolved. Dihexa typically reconstitutes within 1–2 minutes
- Label vial with date, concentration, and compound name
For detailed preparation instructions, see the reconstitution guide. Use the peptide calculator for exact volumes.
Timing, Cycling & Stacking
Timing
- Morning dosing is strongly preferred — dihexa's cognitive-stimulating effects can cause insomnia if taken in the afternoon or evening
- Oral: Take 30–60 minutes before cognitively demanding work for peak effect timing
- SC injection: Onset is faster (15–30 min); adjust timing accordingly
- No food interaction requirement, but empty stomach may improve oral absorption speed
Cycle Length
Short cycles are the norm due to limited long-term safety data:
- Standard cycle: 2–4 weeks on, 4–8 weeks off
- Conservative approach: 2 weeks on, 4 weeks off — recommended for first-time users
- Extended use: Some anecdotal reports describe 6-week cycles, but this exceeds available safety data and is not recommended
The rationale for cycling is twofold: (1) unknown long-term effects of sustained HGF/c-Met pathway amplification, and (2) theoretical receptor desensitization, though this has not been studied specifically for dihexa.
Stacking Considerations
Dihexa is sometimes combined with other nootropic compounds, though no formal interaction studies exist:
- Dihexa + Semax: Different mechanisms (HGF vs BDNF) — theoretically complementary. Use at opposite ends of the day to distinguish effects
- Dihexa + Selank: Selank's anxiolytic properties may counterbalance dihexa's stimulatory effects
- Dihexa + racetams: Common in nootropic communities, though no clinical data on the combination
- Avoid: Combining with other HGF-modulating compounds. Do not stack with angiotensin-pathway drugs (ACE inhibitors, ARBs) without medical oversight
See the cognitive enhancement guide for comprehensive nootropic stacking protocols.
Body Weight & Individual Factors
Unlike many peptides where dosing scales with body weight, dihexa dosing is less clearly weight-dependent due to its mechanism of action (HGF stabilization rather than receptor agonism). However, general principles apply:
- Lighter individuals (<70 kg): Start at the lower end of the dose range (5 mg oral, 1 mg SC)
- Heavier individuals (>90 kg): May use mid-to-upper range, but extreme potency means incremental increases matter more than proportional scaling
- Sensitivity variation: Individual response to dihexa varies significantly. Some users report strong effects at 5 mg oral; others notice little below 15 mg
- Age factor: Animal research showed more pronounced effects in aged subjects with cognitive decline. Older adults may respond at lower doses
The conservative approach: start low (5 mg oral or 1 mg SC), assess for 3–5 days, then titrate upward in small increments.
Storage & Stability
Proper storage is essential to maintain dihexa's activity:
| Form | Storage | Shelf Life |
|---|---|---|
| Capsules (sealed) | Room temperature, cool and dry | 12–24 months |
| Capsules (opened bottle) | Refrigerate (2–8°C) | 6–12 months |
| Lyophilized powder | Freezer (-20°C) long-term; refrigerator (2–8°C) for months | 2+ years frozen; 6–12 months refrigerated |
| Reconstituted solution | Refrigerate (2–8°C) | 21–28 days |
- Protect from light and moisture
- Never freeze reconstituted solution
- Discard if solution becomes cloudy or discolored
See the peptide storage guide for comprehensive storage protocols.